Literature DB >> 6089027

Beta-endorphin contributes to the antihypertensive effect of clonidine in a subset of patients with essential hypertension.

C Farsang, K Varga, L Vajda, J Kapocsi, A Balás-Eltes, G Kunos.   

Abstract

Naloxone [0.4 mg iv.] increased blood pressure and heart rate of 13 clonidine-treated [0.3 mg per os for 3 days] patients with essential hypertension [reacting group] while it has no such effect in 11 clonidine-treated patients [non-reacting gr.] Clonidine increased plasma beta-endorphin concentration of the reacting patients by 17.53 +/- 1.68 pM/1 and in the non-reacting ones by 5.91 +/- 0.88 pM/1. Significant linear correlation was found between the clonidine-induced increase in plasma beta-endorphin level and the naloxone-induced change in mean blood pressure [r = 0.9572, n:24, p less than 0.001]. In another group of 8 patients clonidine [0.15 mg iv.] decreased mean blood pressure but naloxone, 30 min after the clonidine injection, did not reverse the clonidine hypotension. We suggest that beta-endorphin, released by chr. clonidine therapy, contributes to the anti-hypertensive effect only in the reacting group.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089027     DOI: 10.1016/0143-4179(84)90003-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  3 in total

1.  Plasma concentration and vascular effect of beta-endorphin in spontaneously hypertensive and Wistar Kyoto rats.

Authors:  B Bucher; R Bettermann; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

2.  Alpha-methyldopa induces a naltrexone-insensitive antinociception and hypomotility in rats.

Authors:  P L van Giersbergen; E van Duinkerken; C G Sweep; V M Wiegant; J M van Ree; W de Jong
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

3.  Clonidine normalizes low plasma beta-endorphin concentration and blood pressure in young men with mild essential hypertension.

Authors:  K Kraft; R Theobald; K O Stumpe
Journal:  Klin Wochenschr       Date:  1986-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.